The DOI matches its Crossref record; 299 of the 299 references it cites were found in a registry or an index.
Lipid rafts as signaling hubs in cancer cell survival/death and invasion: implications in tumor progression and therapy
Open accessAbstract
Cholesterol/sphingolipid-rich membrane domains, known as lipid rafts or membrane rafts, play a critical role in the compartmentalization of signaling pathways. Physical segregation of proteins in lipid rafts may modulate the accessibility of proteins to regulatory or effector molecules. Thus, lipid rafts serve as sorting platforms and hubs for signal transduction proteins. Cancer cells contain higher levels of intracellular cholesterol and lipid rafts than their normal non-tumorigenic counterparts. Many signal transduction processes involved in cancer development (insulin-like growth factor system and phosphatidylinositol 3-kinase-AKT) and metastasis [cluster of differentiation (CD)44] are dependent on or modulated by lipid rafts. Additional proteins playing an important role in several malignant cancers (e.g., transmembrane glycoprotein mucin 1) are also being detected in association with lipid rafts, suggesting a major role of lipid rafts in tumor progression. Conversely, lipid rafts also serve as scaffolds for the recruitment and clustering of Fas/CD95 death receptors and downstream signaling molecules leading to cell death-promoting raft platforms. The partition of death receptors and downstream signaling molecules in aggregated lipid rafts has led to the formation of the so-called cluster of apoptotic signaling molecule-enriched rafts, or CASMER, which leads to apoptosis amplification and can be pharmacologically modulated. These death-promoting rafts can be viewed as a linchpin from which apoptotic signals are launched. In this review, we discuss the involvement of lipid rafts in major signaling processes in cancer cells, including cell survival, cell death, and metastasis, and we consider the potential of lipid raft modulation as a promising target in cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–299 of 299
Fas ligand is localized to membrane rafts, where it displays increased cell death–inducing activity
Cahuzac, N., Baum, W., Kirkin, V., Conchonaud, F., Wawrezinieck, L., Marguet, D., Janßen, O., Zörnig, M., & Hueber, A. (2005) · Blood · doi:10.1182/blood-2005-07-2883 · Cited by 87
Proteomic analysis of lipid raft-enriched membranes isolated from internal organelles
Poston, C. N., Duong, E., Cao, Y., & Bazemore‐Walker, C. R. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.10.072 · Cited by 87
Gajate, C., Matos-da-Silva, M., Dakir, E. H., Fonteríz, R. I., Álvarez, J., & Mollinedo, F. (2011) · Oncogene · doi:10.1038/onc.2011.446 · Cited by 85
Self-citationBabina, I. S., McSherry, E. A., Donatello, S., Hill, A. D. K., & Hopkins, A. M. (2014) · Breast Cancer Research · doi:10.1186/bcr3614 · Cited by 84
Donatello, S., Babina, I. S., Hazelwood, L. D., Hill, A. D. K., Nabi, I. R., & Hopkins, A. M. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.08.025 · Cited by 84
Ion channels and transporters in metastasis
Stock, C. M., & Schwab, A. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.11.012 · Cited by 82
Roz, A. E., Bard, J., Huvelin, J., & Nazih, H. (2012) · PubMed · Cited by 82
Alkyl ether lipids, ion channels and lipid raft reorganization in cancer therapy
Jaffrès, P., Gajate, C., Bouchet, A. M., Couthon‐Gourvès, H., Chantôme, A., Potier‐Cartereau, M., Besson, P., Bougnoux, P., Mollinedo, F., & Vandier, C. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.06.003 · Cited by 81
Self-citationLotocki, G., Alonso, O. F., Dietrich, W. D., & Keane, R. W. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.3823-04.2004 · Cited by 80
Lipid Raft-Mediated Regulation of Hyaluronan–CD44 Interactions in Inflammation and Cancer
Murai, T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00420 · Cited by 78
Edelfosine Is Incorporated into Rafts and Alters Their Organization
Ausili, A., Torrecillas, A., Aranda, F. J., Mollinedo, F., Gajate, C., Corbalán‐García, S., de Godos, A. M., & Gómez-Fernández, J. C. (2008) · The Journal of Physical Chemistry B · doi:10.1021/jp802165n · Cited by 78
Self-citationVanOosten, R. L., Moore, J. M., Ludwig, A. T., & Griffith, T. S. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2004.12.008 · Cited by 74
The CD95/CD95L signaling pathway: A role in carcinogenesis
Fouqué, A., Debure, L., & Legembre, P. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.04.007 · Cited by 74
Xu, L., Qu, X., Zhang, Y., Hu, X., Yang, X., Hou, K., Teng, Y., Zhang, J., Sada, K., & Liu, Y. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.02.014 · Cited by 73
IGF-1R is overexpressed in poor-prognostic subtypes of multiple myeloma
Chng, W. J., Gualberto, A., & Fonseca, R. (2005) · Leukemia · doi:10.1038/sj.leu.2403997 · Cited by 73
Mesoscale organization of domains in the plasma membrane – beyond the lipid raft
Lu, S. M., & Fairn, G. D. (2018) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2018.1436515 · Cited by 73
Gajate, C., An, F., & Mollinedo, F. (2003) · PubMed · Cited by 72
Self-citationCholesterol levels in patients with multiple myeloma
Yavaşoğlu, İ., Tombuloğlu, M., Kadıköylü, G., Dönmez, A., Çağırgan, S., & Bolaman, Z. (2007) · Annals of Hematology · doi:10.1007/s00277-007-0375-6 · Cited by 72
24-Hydroxycholesterol participates in pancreatic neuroendocrine tumor development
Soncini, M., Corna, G., Moresco, M. A., Coltella, N., Restuccia, U., Maggioni, D., Raccosta, L., Lin, C., Invernizzi, F., Crocchiolo, R., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613332113 · Cited by 71
The oxysterol receptors lxrα and lxrβ suppress proliferation in the colon
Vedin, L., Gustafsson, J.-Α., & Steffensen, K. R. (2012) · Molecular Carcinogenesis · doi:10.1002/mc.21924 · Cited by 70
White, A. B., Galbiati, F., Givogri, M. I., Rosas, A. L., Qiu, X., van Breemen, R. B., & Bongarzone, E. R. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22564 · Cited by 69
The androgen receptor regulates a druggable translational regulon in advanced prostate cancer
Liu, Y., Horn, J. L., Banda, K., Goodman, A. Z., Lim, Y., Jana, S., Arora, S., Germanos, A. A., Wen, L., Hardin, W. R., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw4993 · Cited by 69
Autocrine IGF1 Signaling Mediates Pancreatic Tumor Cell Dormancy in the Absence of Oncogenic Drivers
Rajbhandari, N., Lin, W.-C., Wehde, B. L., Triplett, A. A., & Wagner, K.-U. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.013 · Cited by 68
Remacle-Bonnet, M. M., Garrouste, F. L., Baillat, G., André, F., Marvaldi, J. L., & Pommier, G. J. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62049-4 · Cited by 68
Transit of hormonal and EGF receptor-dependent signals through cholesterol-rich membranes
Freeman, M. R., Cinar, B., Kim, J., Mukhopadhyay, N. K., Vizio, D. D., Adam, R. M., & Solomon, K. R. (2006) · Steroids · doi:10.1016/j.steroids.2006.11.012 · Cited by 68
Aroui, S., Brahim, S., Hamelin, J., WAARD, M. M. D., Bréard, J., & Kénani, A. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0397-8 · Cited by 67
Mollinedo, F., Fernández, M., Hornillos, V., Delgado, J., Amat‐Guerri, F., Acuña, A. U., Nieto-Miguel, T., Villa-Pulgarín, J. A., González-García, C., Ceña, V., et al. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.41 · Cited by 67
Self-citationAssociation between cholesterol intake and pancreatic cancer risk: Evidence from a meta-analysis
Chen, H., Qin, S., Wang, M., Zhang, T., & Zhang, S. (2015) · Scientific Reports · doi:10.1038/srep08243 · Cited by 65
Blockage of voltage-gated K+ channels inhibits adhesion and proliferation of hepatocarcinoma cells
Zhou, Q., Kwan, H. Y., Chan, H.-C., Jiang, J., Tam, S.-C., & Yao, X. (2003) · International Journal of Molecular Medicine · doi:10.3892/ijmm.11.2.261 · Cited by 65
Lipid rafts generate digital‐like signal transduction in cell plasma membranes
Suzuki, K. G. N. (2012) · Biotechnology Journal · doi:10.1002/biot.201100360 · Cited by 64
Motoyama, K., Kameyama, K., Onodera, R., Araki, N., Hirayama, F., Uekama, K., & Arima, H. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.07.010 · Cited by 63
The insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potential
Bieghs, L., Johnsen, H. E., Maes, K., Menu, E., Van Valckenborgh, E., Overgaard, M. T., Nyegaard, M., Conover, C. A., Vanderkerken, K., & De Bruyne, E. (2016) · Oncotarget · doi:10.18632/oncotarget.8982 · Cited by 61
Yeo, C. D., Park, K. H., Park, C. K., Lee, S. H., Kim, S. J., Yoon, H. K., Lee, Y. S., Lee, E. J., Lee, K. Y., & Kim, T. J. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.01.004 · Cited by 61
Lim, S., Duong, H., Choi, J. E., Lee, T.-B., Kang, J., Oh, S. H., & Han, S. I. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr038 · Cited by 61
Murai, T., Miyauchi, T., Yanagida, T., & Sako, Y. (2006) · Biochemical Journal · doi:10.1042/bj20050582 · Cited by 61
Patergnani, S., Missiroli, S., Marchi, S., & Giorgi, C. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00173 · Cited by 59
Nieto-Miguel, T., Gajate, C., & Mollinedo, F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511251200 · Cited by 59
Self-citationNieto-Miguel, T., Gajate, C., González‐Camacho, F., & Mollinedo, F. (2007) · Oncogene · doi:10.1038/sj.onc.1210816 · Cited by 58
Self-citationVilla-Pulgarín, J. A., Gajate, C., Botet, J., Jiménez, A., Justies, N., Varela-M, R. E., Cuesta-Marbán, Á., Müller, I., Modolell, M., Revuelta, J. L., et al. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005805 · Cited by 58
Self-citationTRPM8-androgen receptor association within lipid rafts promotes prostate cancer cell migration
Grolez, G. P., Gordiendko, D. V., Clarisse, M., Hammadi, M., Desruelles, E., Fromont, G., Prevarskaya, N. B., Slomianny, C., & Gkika, D. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1891-8 · Cited by 58
Lipid rafts control human melanoma cell migration by regulating focal adhesion disassembly
Wang, R., Bi, J., Ampah, K. K., Ba, X., Liu, W., & Zeng, X. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.09.007 · Cited by 57
Τheodoratou, E., Farrington, S. M., Tenesa, A., McNeill, G., Cetnarskyj, R., Barnetson, R. A., Porteous, M. E., Dunlop, M. G., & Campbell, H. (2008) · International Journal of Cancer · doi:10.1002/ijc.23769 · Cited by 57
van der Luit, A. H., Budde, M., Verheij, M., & BLITTERSWIJK, W. J. V. (2003) · Biochemical Journal · doi:10.1042/bj20030179 · Cited by 57
Watanabe, T., Okumura, T., Hirano, K., Yamaguchi, T., Sekine, S., Nagata, T., & Tsukada, K. (2016) · Oncology Letters · doi:10.3892/ol.2016.5432 · Cited by 57
Palmitoylation of human FasL modulates its cell death-inducing function
Guardiola-Serrano, F., Rossin, A., Cahuzac, N., Lückerath, K., Melzer, I. M., Mailfert, S., Marguet, D., Zörnig, M., & Hueber, A. (2010) · Cell Death and Disease · doi:10.1038/cddis.2010.62 · Cited by 56
Gajate, C., & Mollinedo, F. (2014) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520614666140309222259 · Cited by 56
Self-citationCholesterol and benign prostate disease
Freeman, M. R., & Solomon, K. R. (2011) · Differentiation · doi:10.1016/j.diff.2011.04.005 · Cited by 56
Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer
Boonyaratanakornkit, V., Hamilton, N. M., Márquez‐Garbán, D. C., Pateetin, P., McGowan, E. M., & Pietras, R. J. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.11.010 · Cited by 56
Lipid Rafts and Clusters of Apoptotic Signaling Molecule-Enriched Rafts in Cancer Therapy
Mollinedo, F., & Gajate, C. (2010) · Future Oncology · doi:10.2217/fon.10.34 · Cited by 55
Self-citationGajate, C., & Mollinedo, F. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.2mr0215-055r · Cited by 54
Self-citationRompay, M. I. V., Solomon, K. R., Nickel, J. C., Ranganathan, G., Kantoff, P. W., & McKinlay, J. B. (2019) · European Journal of Cancer · doi:10.1016/j.ejca.2018.11.033 · Cited by 54
Gusscott, S., Jenkins, C. E., Lam, S. H. L., Giambra, V., Pollak, M., & Weng, A. P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161158 · Cited by 53
Marconi, M., Ascione, B., Ciarlo, L., Vona, R., Garofalo, T., Sorice, M., Gianni, A. M., Locatelli, S. L., Carlo‐Stella, C., Malorni, W., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.389 · Cited by 52
Lipid Rafts and Fas/CD95 Signaling in Cancer Chemotherapy
Gajate, C., & Mollinedo, F. (2011) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/157489211796957766 · Cited by 52
Self-citationGajate, C., & Mollinedo, F. (2015) · APOPTOSIS · doi:10.1007/s10495-015-1104-6 · Cited by 51
Self-citationCholesterol as an Endogenous ERRα Agonist: A New Perspective to Cancer Treatment
Casaburi, I., Chimento, A., Luca, A. D., Nocito, M. C., Sculco, S., Avena, P., Trotta, F., Rago, V., Sirianni, R., & Pezzi, V. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00525 · Cited by 51
Haddon, L. S. J., & Hugh, J. C. (2015) · Clinical & Experimental Metastasis · doi:10.1007/s10585-015-9711-8 · Cited by 50
Insulin-Like Growth Factor Signaling as a Therapeutic Target in Pancreatic Cancer
Rieder, S., W. Michalski, C., Friess, H., & Kleeff, >. (2011) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152011795677454 · Cited by 50
Cuesta-Marbán, Á., Botet, J., Czyz, O., Cacharro, L. M., Gajate, C., Hornillos, V., Delgado, J., Zhang, H., Amat‐Guerri, F., Acuña, A. U., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.425769 · Cited by 49
Self-citationStatin therapy and association with ovarian cancer risk in the New England Case Control (NEC) study
Akinwunmi, B. O., Vitonis, A. F., Titus, L. J., Terry, K. L., & Cramer, D. W. (2018) · International Journal of Cancer · doi:10.1002/ijc.31758 · Cited by 49
Murillo, M. M., Rana, S., Spencer‐Dene, B., Nye, E. L., Stamp, G., & Downward, J. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.12.003 · Cited by 48
O'Sullivan, C., & Dev, K. K. (2015) · Journal of Cell Science · doi:10.1242/jcs.169342 · Cited by 47
Delvecchio, C. J., Bilan, P. T., Nair, P. K., & Capone, J. P. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90394.2008 · Cited by 45
The role of FAS to ezrin association in FAS-mediated apoptosis
Fais, S., Milito, A. D., & Lozupone, F. (2005) · APOPTOSIS · doi:10.1007/s10495-005-0478-2 · Cited by 45
Lim, S., & Han, S. I. (2015) · Oncology Reports · doi:10.3892/or.2015.4076 · Cited by 45
Xu, Z., Ding, T., Haridas, V., Connolly, F., & Gutterman, J. U. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008532 · Cited by 45
Blanářová, O. V., Jelínková, I., Szöőr, Á., Skender, B., Souček, K., Horváth, V., Vaculová, A. H., Anděra, L., Sova, P., Szöllõsi, J., et al. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq220 · Cited by 42
Gbelcová, H., Rimpelová, S., Knejzlík, Z., Šáchová, J., Kolář, M., Strnad, H., Repiská, V., D’Acunto, C. W., Ruml, T., & Vítek, L. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0641-0 · Cited by 41
Sural‐Fehr, T., Singh, H., Cantuti‐Castelvetri, L., Zhu, H., Marshall, M. S., Rebiai, R., Jastrzebski, M. J., Givogri, M. I., Rasenick, M. M., & Bongarzone, E. R. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.036590 · Cited by 41
LXR, prostate cancer and cholesterol: the Good, the Bad and the Ugly.
de Boussac, H., Pommier, A., Dufour, J., Trousson, A., Caira, F., Volle, D. H., Baron, S., & Lobaccaro, J. A. (2013) · Europe PMC (PubMed Central) · Cited by 40
Principles and mechanisms of CD95 activation
Wajant, H. (2014) · Biological Chemistry · doi:10.1515/hsz-2014-0212 · Cited by 40
Heskamp, S., Boerman, O. C., Molkenboer‐Kuenen, J. D. M., Wauters, C. A. P., Strobbe, L. J. A., Mandigers, C. M. P. W., Bult, P., Oyen, W. J. G., van der Graaf, W. T. A., & van Laarhoven, H. W. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117745 · Cited by 40
Lipid Rafts Mediate Ultraviolet Light‐induced Fas Aggregation in M624 Melanoma Cells
Elyassaki, W., & Wu, S. (2006) · Photochemistry and Photobiology · doi:10.1562/2005-12-09-ra-748 · Cited by 40
Romanelli, R. J., Mahajan, K. R., Fulmer, C. G., & Wood, T. L. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22099 · Cited by 39
c-FLIP is a target of the E3 ligase deltex1 in gastric cancer
Hsu, T.-S., Mo, S.-T., Hsu, P., & Lai, M. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0165-6 · Cited by 38
Exogenous Ether Lipids Predominantly Target Mitochondria
Kuerschner, L., Richter, D., Hannibal‐Bach, H. K., Gaebler, A., Shevchenko, A., Ejsing, C. S., & Thiele, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031342 · Cited by 37
Yan, S., Qu, X., Xu, L., Che, X., Ma, Y., Zhang, L., Teng, Y., Zou, H., & Liu, Y. (2014) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000095 · Cited by 37
Liu, Y. (2011) · Molecular Medicine Reports · doi:10.3892/mmr.2011.439 · Cited by 34
Jaipuria, G., Ukmar, T., & Zweckstetter, M. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2789-9 · Cited by 33
Akt signaling dynamics in plasma membrane microdomains visualized by FRET-based reporters
Gao, X., & Zhang, J. (2009) · Communicative & Integrative Biology · doi:10.4161/cib.2.1.7420 · Cited by 32
Dynamics of mitochondrial raft-like microdomains in cell life and death
Sorice, M., Mattei, V., Matarrese, P., Garofalo, T., Tinari, A., Gambardella, L., Ciarlo, L., Manganelli, V., Tasciotti, V., Misasi, R., et al. (2012) · Communicative & Integrative Biology · doi:10.4161/cib.19145 · Cited by 31
Mollinedo, F., & Gajate, C. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.06.40 · Cited by 30
Self-citationLXR, prostate cancer and cholesterol: the Good, the Bad and the Ugly.
de Boussac, H., Pommier, A., Dufour, J., Trousson, A., Caira, F., Volle, D. H., Baron, S., & Lobaccaro, A. (2013) · HAL (Le Centre pour la Communication Scientifique Directe) · Cited by 29
Lipid Rafts, Death Receptors and CASMERs: New Insights for Cancer Therapy
Mollinedo, F., & Gajate, C. (2010) · Future Oncology · doi:10.2217/fon.10.22 · Cited by 28
Self-citationActin‐independent exclusion of CD95 by PI3K/AKT signalling: Implications for apoptosis
Pizon, M., Rampanarivo, H., Tauzin, S., Chaigne-Delalande, B., Daburon, S., Castroviejo, M., Moreau, P., Moreau, J., & Legembre, P. (2011) · European Journal of Immunology · doi:10.1002/eji.201041078 · Cited by 27
Rao‐Bindal, K., Zhou, Z., & Kleinerman, E. S. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.101 · Cited by 27
Zaman, S. N., Resek, M. E., & Robbins, S. M. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1007698 · Cited by 27
Maselli, A., Pierdominici, M., Vitale, C., & Ortona, E. (2015) · APOPTOSIS · doi:10.1007/s10495-015-1093-5 · Cited by 26
Statin use and risk of multiple myeloma: An analysis from the cancer research network
Epstein, M. M., Divine, G., Chao, C., Wells, K. E., Feigelson, H. S., Scholes, D., Roblin, D. W., Yood, M. U., Engel, L. S., Taylor, A., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30745 · Cited by 25
Ausili, A., Martínez-Valera, P., Torrecillas, A., Gómez‐Murcia, V., de Godos, A. M., Corbalán‐García, S., Teruel, J. A., & Gómez-Fernández, J. C. (2018) · Langmuir · doi:10.1021/acs.langmuir.8b01539 · Cited by 25
The Role of Cholesterol in UV Light B‐induced Apoptosis†
George, K. S., Elyassaki, W., Wu, Q., & Wu, S. (2012) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2011.01038.x · Cited by 23
Insulin-like growth factor 1 receptor expression in breast cancer tissue and mammographic density
SUN, W.-Y., Yun, H.-Y., Song, Y., Kim, H., Lee, O.-J., Nam, S. J., & Koo, J.-S. (2015) · Molecular and Clinical Oncology · doi:10.3892/mco.2015.497 · Cited by 23
Resistance to TRAIL Is Mediated by DARPP-32 in Gastric Cancer
Belkhiri, A., Zhu, S., Chen, Z., Soutto, M., & El-Rifai, W. M. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3182 · Cited by 23
FasL-Independent Activation of Fas
Mollinedo, F., & Gajate, C. (2007) · Springer eBooks · doi:10.1007/0-387-34573-6_2 · Cited by 22
Self-citationGmeiner, W. H., Jennings‐Gee, J. E., Stuart, C. H., & Pardee, T. S. (2014) · Leukemia Research · doi:10.1016/j.leukres.2014.11.006 · Cited by 18
The expression of IGF-1R in Helicobacter pylori-infected intestinal metaplasia and gastric cancer
Nakajima, N., Kozu, K., Kobayashi, S., Nishiyama, R., Okubo, R., Akai, Y., Moriyama, M., & Kinukawa, N. (2016) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.16-11 · Cited by 18
The CD95/CD95L Signaling Pathway: A Role in Carcinogenesis
Fouqué, A., & Legembre, P. (2014) · Springer eBooks · doi:10.1007/978-3-662-44006-3_9 · Cited by 15
Death Receptors in Multiple Myeloma and Therapeutic Opportunities
Mollinedo, F. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-564-0_25 · Cited by 14
Self-citationFas/CD95, Lipid Rafts, and Cancer
Mollinedo, F., & Gajate, C. (2017) · Resistance to targeted anti-cancer therapeutics · doi:10.1007/978-3-319-56805-8_9 · Cited by 2
Self-citation
Cited by
Lipid composition of the cancer cell membrane
Szlasa, W., Zendran, I., Zalesińska, A., Tarek, M., & Kulbacka, J. (2020) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-020-09846-4 · Cited by 435
Cholesterol metabolism: New functions and therapeutic approaches in cancer
Xu, H., Zhou, S., Tang, Q., Xia, H., & Bi, F. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188394 · Cited by 365
Obesity, Diabetes, and Increased Cancer Progression
Kim, D.-S., & Scherer, P. E. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0077 · Cited by 302
Duranti, C., Iorio, J., Manganelli, V., Bagni, G., Colasurdo, R., Lottini, T., Martinelli, M., Capitani, C., Boso, G., D’Alessandro, F. N., et al. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02321-2 · Cited by 8
“Hence, LRs are emerging as pivotal membrane hubs to modulate intracellular pathways [13 – 16] that are particularly relevant in cancer [17], and may represent putative targets for anticancer drug development [18].”
Metadata
- Authors
- Mollinedo, F., & Gajate, C.
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2020-05
- Volume
- 61
- Issue
- 5
- Pages
- 611-635
- ISSN
- 0022-2275 (ISSN-L)
- OpenAlex
- W3003322304
- Cited by
- 279
- References
- 299
- FWCI
- 10.03
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.